These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12455576)

  • 21. Contribution of iron deficiency to anemia in chronic renal failure.
    Gupta M; Kannan M; Gupta S; Saxena R
    Indian J Pathol Microbiol; 2003 Oct; 46(4):563-4. PubMed ID: 15025343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination index of soluble transferrin receptor and mean corpuscular hemoglobin for evaluating iron deficiency in end-stage renal disease.
    Choi JW
    Ann Hematol; 2007 Jan; 86(1):75-7. PubMed ID: 17013644
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombocytosis in EPO-treated dialysis patients may be mediated by EPO rather than iron deficiency.
    Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):733-6. PubMed ID: 19303685
    [No Abstract]   [Full Text] [Related]  

  • 24. One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis.
    Offner G; Hoyer PF; Latta K; Winkler L; Brodehl J; Scigalla P
    Pediatr Nephrol; 1990 Sep; 4(5):498-500. PubMed ID: 2242315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulins modify the response to erythropoietin in a CAPD patient.
    al Shohaib S; Abunijem Z
    Nephron; 1996; 73(4):720. PubMed ID: 8856284
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythropoietin escape in five CAPD patients.
    Williams P; Jones J
    Nephron; 1996; 73(2):354. PubMed ID: 8773387
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
    Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
    Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients.
    Kooistra MP; Marx JJ
    Nephrol Dial Transplant; 1998 Oct; 13(10):2578-82. PubMed ID: 9794563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anemia in peritoneal dialysis patients].
    Lausević M; Nesić V; Jovanović N; Stojimirović B
    Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron supplementation in end-stage renal disease patients.
    Matzke GR
    Am J Kidney Dis; 1999 Mar; 33(3):595-7. PubMed ID: 10070926
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
    Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron management in end-stage renal disease.
    Fishbane S; Maesaka JK
    Am J Kidney Dis; 1997 Mar; 29(3):319-33. PubMed ID: 9041207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Egg on the table.
    Kazama JJ; Kaneko Y
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):14-5. PubMed ID: 19129315
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble transferrin receptor and immature reticulocytes are not useful for distinguishing iron-deficiency anemia from heterozygous beta-thalassemia.
    de Lima GA; Grotto HZ
    Sao Paulo Med J; 2003 Mar; 121(2):90-1. PubMed ID: 12870058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract]   [Full Text] [Related]  

  • 39. Soluble transferrin receptor: a differentiating marker between iron deficiency anaemia and anaemia of chronic disorders.
    Saboor M; Moinuddin ; Naureen A
    J Ayub Med Coll Abbottabad; 2011; 23(3):115-8. PubMed ID: 23272450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
    Macdougall IC; Cavill I; Davies ME; Hutton RD; Coles GA; Williams JD
    Contrib Nephrol; 1989; 76():219-26. PubMed ID: 2582780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.